Debra Ritzwoller to Early Detection of Cancer
This is a "connection" page, showing publications Debra Ritzwoller has written about Early Detection of Cancer.
Connection Strength
3.645
-
Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening. J Thorac Oncol. 2022 12; 17(12):1355-1364.
Score: 0.571
-
Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions. J Natl Cancer Inst Monogr. 2022 Jul 05; 2022(59):42-50.
Score: 0.565
-
A Feasible Path to Reductions in Racial and Ethnic Disparities in Lung Cancer Screening? JNCI Cancer Spectr. 2022 May 02; 6(3).
Score: 0.558
-
Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance. J Gen Intern Med. 2020 04; 35(4):1143-1152.
Score: 0.476
-
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prev Res (Phila). 2020 02; 13(2):129-136.
Score: 0.474
-
Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium. JCO Clin Cancer Inform. 2023 Sep; 7:e2300063.
Score: 0.153
-
Individuals Eligible for Lung Cancer Screening Less Likely to Receive Screening When Enrolled in Health Plans With Deductibles. Med Care. 2023 Oct 01; 61(10):665-673.
Score: 0.152
-
Smoking status and the association between patient-level factors and survival among lung cancer patients. J Natl Cancer Inst. 2023 08 08; 115(8):937-948.
Score: 0.152
-
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open. 2021 10 01; 4(10):e2128176.
Score: 0.134
-
Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
Score: 0.125
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.103
-
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study. Ann Intern Med. 2024 Jan; 177(1):18-28.
Score: 0.039
-
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
Score: 0.036
-
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
Score: 0.035
-
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 10; 151:106595.
Score: 0.033
-
Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015 Jun; 9(2):201-7.
Score: 0.021
-
Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012 Nov 15; 118(22):5644-51.
Score: 0.017